EndoLISA® Endotoxin Detection Assay based on ELISA-technology
Features
EndoLISA® is intended for in vitro quantitative determination of lipopolysaccharide (LPS) in aqueous samples and biological fluids in non-regulated fields.
Warning: EndoLISA® is not intended for the diagnosis of human or animal diseases.
Note: EndoLISA® is not suitable for the detection of endotoxin in serum, plasma and blood samples.
- Overcomes limitations of existing methods, such as the need for extensive dilution
- Reduced matrix effects due to integrated washing step
- Robust assay with excellent reproducibility
- Broad measurement range (0.05–500 EU/ml)
- Broad pH range (pH4 – pH9)
- Less interference at high salt conditions e.g. NaCl, GdnHCl
- All reagents necessary to run the assay included in the kit
- Saves the diminishing horseshoe crab population
Hetereogeneous fluorescence microplate assay using a phage-derived capture molecule for the quantitative binding and determination of endotoxins (lipopolysaccharides). The world’s first endotoxin detection system based on ELISA-technology. A highly robust method with unprecedented salt and detergent tolerance. Developed and intended for complex sample matrices.
-Dhanasooraj D, Kumar RA, Mundayoor S. Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles. Int J Nanomedicine. 2013;8:835-43
-Toussaint M, Fievez L, Desmet CJ, Pirottin D, Farnir F, Bureau F, Lekeux P. Increased hypoxia-inducible factor 1alpha expression in lung cells of horses with recurrent airway obstruction. BMC Vet Res. 2012;8:64